dinoprost and Dystocia

During late bovine pregnancy, several hormones are involved to maintain and develop a successful result with a live calf. These hormones are e.g., progesterone, high levels during the whole pregnancy period, originating from the corpus luteum, maternal adrenals and placenta. Oestrone sulphate, oestrone in its conjugated form, shows elevated levels from about mid-pregnancy until the third stage of parturition (expelling of the fetal membranes). For the onset of normal parturition and the parturition process as such, a change from progesterone to oestrone synthesis is crucial. The increasing levels of oestrone are time-related to an increased synthesis of prostaglandin F(2alpha) (reflected as elevated levels of 15-ketodihydro-PGF(2alpha)) causing prepartal luteolysis and several hormones are then involved in the labour process such as prostaglandin F(2alpha), cortisol and oxytocin. Cortisol might also be an indicator of stressful events for the dam. Levels of pregnancy associated glycoproteins (PAGs), originating from the trophoblastic binucleate cells, are increasing during the last 10 days prior to parturition. All the mentioned hormones have certain functions during pregnancy, more or less understood. However, could deviations from the expected profiles during late bovine pregnancy indicate impaired fetal well-being or be of importance for reproductive performance during the postpartum period? Abortions, stillbirths or dystocia are situations where endocrine profiles might predict the status of the calf. There are two possible approaches to study the endocrine changes in late pregnancy-to follow spontaneous cases of normal or impaired pregnancies or to experimentally disturb the gestation or induce parturition. We have in one study followed pregnant animals to depict reproductive disturbances, both animals with expected normal parturitions and animals where the sire of the calf has given rise to a high incidence of stillborn calves. The number of stillborn calves or dystocia has been small and so far it has not been possible to obtain a clear picture of the usefulness of endocrine parameters to follow fetal well being, but some of the hormonal parameters show a deviating profile. In a small group of animals with induced parturition (PGF(2alpha)), two out of three had parturition problems and one of these animals had a stillborn calf. All three animals had retained fetal membranes. It was possible to demonstrate a deviating endocrine profile in the cow ha

Topics: Animals; Cattle; Cattle Diseases; Dinoprost; Dystocia; Estrone; Female; Fetus; Hormones; Hydrocortisone; Labor, Induced; Oxytocin; Pregnancy; Pregnancy Complications; Progesterone

To evaluate the effect of 2 postpartum prostaglandin F2 alpha (PGF 2 alpha) treatment protocols on reproductive performance of dairy cows at risk for low fertility. In addition, various medical conditions in cows that are recognized as having adverse effects on fertility were evaluated as criteria for fertility treatment.. Prospective study.. 291 cows with, and 271 cows without, risk factors for low fertility.. Cows at risk for low fertility were randomly assigned to 2 treatment groups. Group-1 cows received 3 i.m. injections of PGF2 alpha at weekly intervals after parturition, and group-2 cows received 1 i.m. injection of PGF2 alpha 17 to 24 days after parturition.. Compared with a single PGF2 alpha treatment 17 to 24 days after parturition, there was no added benefit of 3 treatments with PGF2 alpha 3 to 10, 10 to 17, and 17 to 24 days after parturition in cows at risk for low fertility. Cows without risk factors for low fertility had 20% higher pregnancy rates, compared with cows with risk factors for low fertility. Twinning had a negative effect on future fertility.. Results of this study indicate that further consideration should be given to the timing and intervals of PGF2 alpha administration after parturition. Risk factors for low fertility, such as retained placenta, twins, and assisted calvings, are valid criteria to evaluate different treatment options to improve fertility in dairy cows.

Topics: Animals; Cattle; Cattle Diseases; Confidence Intervals; Dinoprost; Dystocia; Endometritis; Female; Infertility, Female; Injections, Intramuscular; Placenta, Retained; Pregnancy; Pregnancy Rate; Pregnancy, Multiple; Proportional Hazards Models; Prospective Studies; Risk Factors; Twins

One hundred and thirty dairy cattle that had undergone a caesarean operation because of dystocia were assigned either to a treatment group, receiving 25 mg dinoprost (synthetic prostaglandin F2 alpha) or to a control group, receiving 5 ml saline solution, administered intramuscularly after removal of the calf and reposition of the closed uterus into the abdominal cavity. In 52 of 65 (80.0 per cent) prostaglandin-treated animals and in 38 of 65 (58.5 per cent) control animals the complete placenta was expelled within 12 hours. This difference was statistically significant (P < 0.05).

Topics: Animals; Cattle; Cattle Diseases; Cesarean Section; Dinoprost; Dystocia; Female; Injections, Intramuscular; Placenta; Postpartum Period; Pregnancy; Time Factors

This study aimed to examine the etiology of canine dystocia by measuring the relative expression of oxytocin receptor (OXTR) mRNA and the concentration of serum progesterone, plasma PGF

Topics: Animals; Calcium; Dinoprost; Dog Diseases; Dogs; Dystocia; Female; Pregnancy; Progesterone; Receptors, Oxytocin

The present study compared some of the hormonal and biochemical constituents of serum from eutocic and dystocic one-humped camels (Camelus dromedarius). Sera were harvested from eutocic (n = 9) and dystocic (n = 20) camels within the first 15 minutes after delivery. Although there were no differences in the concentrations of estradiol-17β (E2) and prostaglandin F2α (PGF2α) between the eutocic and the dystocic animals, the level of progesterone (P4) and cortisol was significantly higher (P < 0.01) in animals that experienced dystocia than those that had a normal birth. There were no differences between the concentrations of alkaline phosphatase, aspartate aminotransferase, calcium, cholesterol, creatine kinase, creatinine, or magnesium (Mg) in eutocic and dystocic animals. The nitric oxide concentration was significantly higher (P < 0.01) in the serum from animals with dystocia than those that had normal births. By contrast, the serum concentrations of glucose, phosphorus (P), and triglycerides were significantly lower (P < 0.01) in eutocic camels compared with dystocic camels. As the delayed decline of P4 is reported to be the major hormonal difference between eutocic and dystocic camels, we propose that the insensitivity of corpus luteum to luteolytic action may be a cause of dystocia. Moreover, stress and hormonal changes may affect the metabolic traits in dystocia camels.

Topics: Alkaline Phosphatase; Animals; Blood Glucose; Calcium; Camelus; Creatine Kinase; Dinoprost; Dystocia; Estrogens; Female; Glutamyl Aminopeptidase; Hydrocortisone; Magnesium; Nitric Oxide; Phosphorus; Pregnancy; Triglycerides

Three dairy heifers (A, B and C) were induced to parturition with two prostaglandin (PG) F(2alpha) injections on day 268 and 269 of pregnancy. Signs of approaching parturition were carefully observed. The following parameters were registered: degrees of calving difficulty, date and time of parturition, calf's birth weight and calf's sex. Body temperature was measured and blood samples were taken every 3 h 3 days before the first PGF(2alpha) injection until 3 days after parturition. The plasma concentrations of the PGF(2alpha) metabolite, progesterone, cortisol, oestrone sulphate and pregnancy associated glycoproteins (PAGs) were analysed. Heifers A, B and C delivered 48, 51 and 57 h after the first PGF(2alpha) injection, respectively. Heifer A delivered without any signs of calving difficulty, whereas, the parturition was considered to be slight and moderate difficulty occurred in the delivery of heifers B and C, respectively. The calf of heifer C, without any abnormal gross-evidences, was stillborn. All animals had retained foetal membranes. A slight increase of the PGF(2alpha) metabolite at the time of parturition was found only in heifer C, whereas the levels dramatically increased in all animals 15-24 h after parturition. At the same time, progesterone levels decreased within 3 h after the first PGF(2alpha) injection (P < 0.05) and reached 0.8, 2.7 and 12.4 nmol/l at the time of parturition in heifers A, B and C, respectively. High release of cortisol at the time of parturition was seen in heifer C. Rising levels of oestrone sulphate around the time of parturition were recorded in all heifers, whereas, increasing levels of PAGs were recorded only in heifer A. In conclusion, the patterns of the PGF(2alpha) metabolite, cortisol, progesterone and PAGs were changed in the cases of calving difficulty and stillbirth after PGF(2alpha)-induction of parturition. However, the relationship between oestrone sulphate and PAGs and the status of foetal well being prior to parturition require further elucidation.

Topics: Animals; Cattle; Cattle Diseases; Dinoprost; Dystocia; Estrone; Female; Fetal Death; Fetal Monitoring; Gestational Age; Hormones; Hydrocortisone; Kinetics; Labor, Induced; Labor, Obstetric; Pregnancy; Pregnancy Proteins; Progesterone

Plasma concentrations of progesterone, oestradiol-17beta, oestrone, oestrone sulphate and PGFM have been measured daily during the first peri-partum period of 45 Hereford x Friesian heifers bred at 11 months of age. Anatomical measurements of dam and calf were also recorded. Twelve of the calvings were scored easy, 33 difficult. Each of five models (fitted by linear logistic regression) relating difficulty of calving to the hormonal and anatomical measurements, predicts with at least 94% accuracy the calving score (easy or difficult) among the calvings. The models predict that increases of progesterone concentration on the day before calving, of oestrone sulphate concentration on the day after calving and of heifer heart girth decrease the odds of difficult calving, whereas increases of heifer body length and of calf head circumference increase the odds of difficult calving.

Topics: Animal Feed; Animals; Animals, Newborn; Body Weight; Cattle; Cattle Diseases; Dinoprost; Dystocia; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Insemination, Artificial; Labor, Obstetric; Logistic Models; Male; Multivariate Analysis; Numerical Analysis, Computer-Assisted; Pregnancy; Progesterone; Radioimmunoassay

Objectives of this study were to show postpartum plasma PGF2 alpha metabolite (PGFM) profile, to clarify whether endogenous PGF2 alpha plays a certain role in the uterine involution in cows with dystocia and/or retained placenta, and to examine the effects of fenprostalene, a long-acting PGF2 alpha analog, on the uterine involution and reproductive performance of the cows with abnormal puerperium. A group of 27 cows with dystocia and/or retained placenta showed a massive release of PGF2 alpha after parturition as indicated by a rise of plasma concentrations of PGFM, significantly higher than 33 cows with normal puerperium. The duration of the elevated plasma PGFM concentrations in the cows with abnormal puerperium was shorter than that of the normal cows. In cows with normal puerperium, those showing relatively longer duration of elevated plasma PGFM levels needed a shorter period for postpartum uterine involution than the cows showing a shorter duration of the PGFM elevation (P < 0.01), while no such relationship was observed in cows with abnormal puerperium. In field trials, an administration of an exogenous PGF2 alpha, fenprostalene, at 7 to 10 days (78 cows) or 14 to 28 days postpartum (74 cows) was found to be effective in facilitating uterine involution and resumption of ovarian cyclicity, and improved reproductive performance. It may be concluded that a large amount of PGF2 alpha is released for a relatively shorter period in cows after dystocia and/or retained placenta and the elevation of PGFM is not responsible for the uterine involution. The administration of the exogenous PGF2 alpha was shown to be effective at improving the postpartum reproductive performance of cows with abnormal puerperium.

Topics: Abortifacient Agents, Nonsteroidal; Animals; Cattle; Cattle Diseases; Dinoprost; Dose-Response Relationship, Drug; Dystocia; Endometritis; Female; Placenta, Retained; Postpartum Period; Pregnancy; Prostaglandins F, Synthetic; Random Allocation; Reproduction; Time Factors; Uterus

Holstein cows (n = 445) that had experienced dystocia, retained fetal membrane, or both at parturition were used to determine the effects of GnRH, PGF2 alpha, or both on various reproductive measurements. Cows affected with these conditions were assigned randomly to each of four treatment groups. One group of cows was untreated, and three groups received GnRH once at 12 d postpartum, or GnRH at 12 plus PGF2 alpha at 26 d postpartum, or PGF2 alpha given at 12 and 26 d postpartum. Another group of 191 cows that calved normally were untreated. Conception rate after first AI was higher for cows treated with PGF2 alpha at 12 and 26 d postpartum. Cows affected with dystocia, retained fetal membranes, or both and treated early postparum with GnRH alone or followed 14 d later with PGF2 alpha did not have improved reproductive performance. Cows calving during the summer months of June through September experienced a reduction in the reproductive traits examined.

Topics: Animals; Cattle; Cattle Diseases; Dinoprost; Dystocia; Extraembryonic Membranes; Female; Fertility; Gonadotropin-Releasing Hormone; Obstetric Labor Complications; Pregnancy; Reproduction

Crossbred beef heifers (N = 36) were assigned to one of three treatment groups: untreated controls (C; N = 15); Group R4, treated with pig relaxin (1.0 mg i.m.) 4 days pre partum (N = 11); or Group R7, treated with pig relaxin (1.0 mg i.m.) 7 days pre partum (N = 10). Bioactivity of the pig relaxin (UMC-R-P8) was determined by the mouse interpubic ligament assay to be greater than or equal to 3000 U/mg, both before and after the experiment was conducted. Peripheral serum immunoreactive relaxin values were 7.5, 3.4, 2.5, and 1.5 ng/ml at 2, 4, 6 and 8 h after injection of relaxin, respectively. Gestation lengths were 282.9 +/- 1.1, 285.5 +/- 1.3 and 285.6 +/- 1.5 days for Groups C, R4 and R7 (C vs R4 + R7; P congruent to 0.08). Calving difficulty score (1 to 4) tended to be greater (P congruent to 0.08) for Group R4 and R7 heifers (C vs R4 + R7; 1.3 +/- 0.24 vs 1.75 +/- 0.28 + 2.04 +/- 0.32), but the incidences of dystocia and retained placentae were not influenced by treatment (P greater than or equal to 0.10). The mean concentration and concentration profile of daily serum progesterone, oestradiol-17 beta, dihydroprostaglandin F-2 alpha and relaxin were not affected by treatment from 6 days pre partum through 2 days post partum. Cervical diameter, cervical softness score, pelvic measurements, and vulva opening length during the periparturient period were not affected (P greater than or equal to 0.10) by treatment, but all of these characteristics changed over time (P less than or equal to 0.01), relative to calving. We conclude that i.m. administration of pig relaxin (greater than or equal to 3000 U) does not effectively alter periparturient characteristics of beef heifers. Discrepancies between these results and those reported for intracervical administration cannot be readily explained.

Topics: Animals; Cattle; Cattle Diseases; Dinoprost; Dose-Response Relationship, Drug; Dystocia; Estradiol; Female; Gestational Age; Injections, Intramuscular; Pregnancy; Progesterone; Relaxin; Swine